drugset / Trial / NCT01330563
Drug-drug Interaction Study (CKD-501, Ketoconazole)
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to assess the effect of Ketoconazole on the pharmacokinetic characteristics of CKD-501 in healthy subject.
Timeline
- Start
- 2011-03
- Primary completion
- 2011-06
- Completion
- 2011-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketoconazole | Small molecule | 200 mg | Oral |
| Subject | Lobeglitazone | Small molecule | 0.5 mg | Oral |